| Literature DB >> 31124011 |
Jia-Huan Shang1,2, Guo-Wei Xu1,2, Hong-Tao Zhu1,3, Dong Wang1,3, Chong-Ren Yang1, Ying-Jun Zhang4,5.
Abstract
Four new protopanaxatriol-type triterpenes (1-2) and glucosides (3-4), were isolated from the rot roots of Panax notoginseng (Burk.) Chen, along with four known ones (5-8). Their structures were elucidated on the basis of extensive spectroscopic analysis (HRESIMS, NMR, UV, IR, and OR) and acidic hydrolysis. The possible transformation pathway of these compounds were also speculated from ginsenoside Rg1. Compound 1, with a unique α,β-unsaturated ketene in its side chain, showed significant inhibitory effects against NO production on Murine macrophage cells (IC50 = 4.12 ± 0.20 μM) and comparable cytotoxicities against five human cancer cell lines (myeloid leukemia HL-60, lung cancer A-549 cells, hepatocellular carcinoma SMMC7721, breast cancer MCF-7, and colon cancer SW480) to positive control, cisplatin (DDP).Entities:
Keywords: Cytotoxicity; Inhibition on NO production; Panax notoginseng; Rot root; Triterpenes and saponins
Year: 2019 PMID: 31124011 PMCID: PMC6646631 DOI: 10.1007/s13659-019-0211-4
Source DB: PubMed Journal: Nat Prod Bioprospect ISSN: 2192-2209
Fig. 1Compounds 1–8 isolated from the rot roots of P. notoginseng
13C (150 MHz) NMR data of 1–4 in pyridine-d5 (δ in ppm)
| No. |
|
|
|
| No. |
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| 1 | 39.8 | 39.7 | 40.3 | 40.5 | 19 | 17.9 | 17.9 | 17.5 | 18.7 |
| 2 | 28.6 | 33.5 | 33.8 | 33.7 | 20 | 72.9 | 73.7 | 83.5 | 73.5 |
| 3 | 78.9 | 218.7 | 219.1 | 219.0 | 21 | 27.5 | 27.4 | 23.7 | 27.5 |
| 4 | 40.8 | 48.1 | 48.1 | 48.6 | 22 | 33.2 | 38.9 | 40.3 | 36.3 |
| 5 | 62.2 | 59.1 | 59.5 | 58.4 | 23 | 30.5 | 31.4 | 127.0 | 23.5 |
| 6 | 68.1 | 67.2 | 67.3 | 79.8 | 24 | 203.2 | 76.5 | 138.6 | 126.8 |
| 7 | 48.0 | 45.1 | 45.8 | 43.8 | 25 | 145.2 | 150.4 | 81.8 | 131.3 |
| 8 | 41.6 | 41.6 | 41.0 | 40.7 | 26 | 124.9 | 110.8 | 25.6 | 26.3 |
| 9 | 50.6 | 53.5 | 49.0 | 48.8 | 27 | 18.3 | 18.4 | 25.9 | 18.2 |
| 10 | 39.8 | 38.6 | 38.6 | 38.9 | 28 | 32.4 | 32.4 | 32.6 | 32.3 |
| 11 | 32.6 | 40.6 | 32.2 | 33.3 | 29 | 17.0 | 20.3 | 20.5 | 20.2 |
| 12 | 71.6 | 211.4 | 70.7 | 71.2 | 30 | 17.5 | 17.4 | 16.7 | 17.1 |
| 13 | 48.6 | 56.5 | 49.8 | 49.3 | 1′ | 98.8 | 105.8 | ||
| 14 | 52.1 | 56.3 | 51.9 | 52.2 | 2′ | 75.8 | 75.9 | ||
| 15 | 31.8 | 32.6 | 31.1 | 31.7 | 3′ | 79.4 | 80.1 | ||
| 16 | 27.3 | 24.9 | 26.8 | 27.3 | 4′ | 72.1 | 72.4 | ||
| 17 | 55.2 | 44.4 | 52.5 | 55.1 | 5′ | 78.8 | 78.6 | ||
| 18 | 18.0 | 16.3 | 18.2 | 16.5 | 6′ | 63.5 | 63.6 |
1H (600 MHz) NMR data of 1–4 in pyridine-d5 (δ in ppm, J in Hz)
| No. |
|
|
|
|
|---|---|---|---|---|
| 1 | 1.68 m, 1.03 m | 1.55 m | 1.80 m, 1.59 m | 1.75 m, 1.56 m |
| 2 | 1.93 m, 1.86 m | 2.81 m, 2.30 m | 2.80 m, 2.32 m | 2.83 m, 2.31 m |
| 3 | 3.54 d (10.8) | |||
| OH-3 | 5.79 s | |||
| 5 | 1.23 d (10.4) | 1.95 d (10.8) | 1.93 m | 2.15 d (10.6) |
| 6 | 4.43 t (8.5) | 4.27 m | 4.23 m | 4.29 td (10.7, 3.8) |
| OH-6 | 5.32 s | 5.85 s | 5.71 s | |
| 7 | 1.98 m | 1.93 m | 1.88 m | 2.64 dd (12.9, 3.8) |
| 1.91 m | 1.89 m | 1.93 d (12.1) | ||
| 9 | 1.60 m | 1.99 dd (13.0, 4.3) | 1.66 m | 2.06 m |
| 11 | 2.16 m, 1.25 m | 2.31 m | 2.03 m, 1.53 m | 2.04 m, 2.15 m |
| 12 | 3.95 t (10.8) | 4.03 m | 3.90 m | |
| OH-12 | 7.39 s | 7.40 s | 7.29 s | |
| 13 | 2.09 t (10.9) | 3.43 d (9.6) | 2.01 m | 1.66 m |
| 15 | 1.58 m | 1.88 m, 1.19 m | 1.51 m, 1.01 m | 1.69 m, 1.28 m |
| 16 | 1.88 m, 1.42 m | 2.16 m, 1.88 m | 1.80 m, 1.44 m | 1.84 m, 1.38 m |
| 17 | 2.37 m | 2.78 m | 2.49 m | 2.34 m |
| 18 | 1.01 s | 1.24 s | 0.88 s | 1.13 s |
| 19 | 1.10 s | 0.82 s | 0.74 s | 0.88 s |
| OH-20 | 7.02 | 5.48 | 7.03 | |
| 21 | 1.38 s | 1.47 s | 1.62 s | 1.43 s |
| 22 | 3.31 m | 2.15 m | 3.08 dd (14.1, 6.1) | 2.05 m |
| 3.02 m | 1.88 m | 2.76 m | 2.71 m | |
| 23 | 2.39 m, 2.05 m | 2.19 m, 2.02 m | 6.21 m | 2.62 m, 2.29 m |
| 24 | 4.42 t (6.0) | 6.08 d (15.7) | 5.35 tt (7.1, 1.2) | |
| OH-24 | 6.41 s | |||
| OOH-25 | 14.37 s | |||
| 26 | 6.06 s, 5.66 s | 5.25 m, 4.97 m | 1.59 s | 1.68 s |
| 27 | 1.89 s | 1.92 s | 1.60 s | 1.64 s |
| 28 | 2.02 s | 1.67 s | 1.68 s | 1.79 s |
| 29 | 1.47 s | 1.70 s | 1.73 s | 1.89 s |
| 30 | 0.97 s | 0.91 s | 1.09 s | 0.88 s |
| 1′ | 5.26 d (7.7) | 5.04 d (7.8) | ||
| 2′ | 4.04 m | 4.08 m | ||
| 3′ | 4.27 m | 4.25 m | ||
| 4′ | 4.17 m | 4.23 m | ||
| 5′ | 4.03 m | 3.96 m | ||
| 6′ | 4.55 d (11.4) | 4.57 d (11.3) | ||
| 4.35 m | 4.38 m |
Fig. 2Key 1H-1H COSY and 1H-13C HMBC correlations of compounds 1–4
Fig. 3The possible transformation pathway of 1–8 from ginsenoside Rg1
Cytotoxicities of compound 1 against five human cancer cell lines
| Cancer cells | IC50 ± SD (μM) | ||
|---|---|---|---|
|
| DDP | Taxol | |
| Myeloid leukemia HL-60 | 19.12 ± 0.21 | 2.87 ± 0.08 | < 0.008 |
| Lung cancer A-549 | 16.30 ± 0.21 | 20.62 ± 2.70 | < 0.008 |
| Hepatocellular carcinoma SMMC7721 | 16.69 ± 0.33 | 17.40 ± 0.51 | < 0.008 |
| Breast cancer MCF-7 | 16.78 ± 0.32 | 14.96 ± 0.45 | < 0.008 |
| Colon cancer SW480 | 13.58 ± 0.71 | 14.34 ± 1.15 | < 0.008 |
Data expressed as mean ± SD (n = 3)